28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
This non-invasive approach identifies whether the symptoms are originating from the wrist, neck, or both
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution
Thats why we offer competitive pricing on all of our treatments, including $19 B-12 injections
Hydroxocobalamin is the form typically used in intramuscular injections for treating B12 deficiency in the UK, as recommended by NICE guidelines